← Back to AIDX

20/20 Biolabs, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 14/08/2026Mar 2026Filed 14/08/2026Jun 2025Filed 14/08/2026Mar 2025Filed 14/08/2026
$0.7$0.4$0.5$0.6
−$1.5−$2.2−$0.8−$0.8
−$0.26−$0.28−$0.17−$0.16
117.74.84.8

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.